Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.4
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Collaboration revenue $ 37,255 $ 129,799
Operating expenses:    
Research and development 3,745,940 4,265,866
General and administrative 1,903,709 2,078,885
Total operating expenses 5,649,649 6,344,751
Loss from operations (5,612,394) (6,214,952)
Foreign exchange gain 70,252 13,971
Net loss $ (5,542,142) $ (6,200,981)
Per share information:    
Net loss per share, basic and diluted $ (0.80) $ (1.44)
Weighted average shares outstanding, basic and diluted 6,920,678 4,306,644